NEW YORK (GenomeWeb) – GATC Biotech today announced it has signed a worldwide commercial agreement with Molecular Health.

Under the terms of the agreement, GATC Biotech will market and support Molecular Health's TreatmentMap tumor profiling system, which includes a next-generation sequencing-based test which looks at 500 cancer-linked genes to guide treatment strategies. Molecular Health has launched TreatmentMap in the US and in Germany and GATC Biotech will work with the company to increase adoption of the technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.